Third Harmonic Bio, Inc.
THRD
$5.15
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.89% | 31.54% | 17.47% | 5.62% | -3.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.06% | 57.99% | 57.40% | 31.32% | -5.82% |
| Operating Income | -48.06% | -57.99% | -57.40% | -31.32% | 5.82% |
| Income Before Tax | -101.55% | -91.73% | -87.92% | -41.63% | 13.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -101.55% | -91.73% | -87.92% | -41.63% | 13.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.55% | -91.73% | -87.92% | -41.63% | 13.53% |
| EBIT | -48.06% | -57.99% | -57.40% | -31.32% | 5.82% |
| EBITDA | -48.10% | -58.06% | -57.46% | -31.30% | 5.90% |
| EPS Basic | -80.40% | -70.60% | -80.54% | -38.15% | 13.50% |
| Normalized Basic EPS | -57.66% | -70.59% | -80.54% | -38.19% | 13.53% |
| EPS Diluted | -80.40% | -70.60% | -80.54% | -38.15% | 13.50% |
| Normalized Diluted EPS | -57.66% | -70.59% | -80.54% | -38.19% | 13.53% |
| Average Basic Shares Outstanding | 11.70% | 12.41% | 4.10% | 2.49% | 0.00% |
| Average Diluted Shares Outstanding | 11.70% | 12.41% | 4.10% | 2.49% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |